Compositions and methods for adoptive cell therapy for cancer
US12178830B2 · kind B2 · utility
0Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2018 |
| Grant date | Dec 31, 2024 |
| Priority date | — |
| Expiry date | Apr 23, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions and methods for adoptive cell therapy comprising engineered immune cells that express a tumor antigen-targeted chimeric antigen receptor and a prodrug converting enzyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.